FOLD

Amicus Therapeutics, Inc. · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website amicusrx.com
Employees(FY) 484
ISIN US03152W1099

Performance

-4.26%

-19.57%

-20.1%

-2.52%

-31.92%

YTD

-9.21%

Profile

Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. The company also develops AT-GAA, a novel treatment paradigm for Pompe disease; and enzyme replacement therapies for Pompe diseases. It has collaboration and license agreements with Nationwide Children's Hospital; University of Pennsylvania; and GlaxoSmithKline. The company was incorporated in 2002 and is headquartered in Philadelphia, Pennsylvania.

Advanced Technical Analysis

Technical Analysis of FOLD 2024-11-22

The stock indicators reflect a bearish sentiment overall, with a Moving Average Score of 10 indicating strong downward momentum, a neutral Oscillators Score of 50 suggesting indecision, and a Technical Score of 30 reinforcing the bearish outlook. This combination signals caution for potential investors as the market appears to be struggling to g...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of FOLD

Stock Rank

Recent News & Updates

2024-11-19 11:40
HALO vs. FOLD: Which Stock Should Value Investors Buy Now?(Zacks)
2024-11-08 06:47
Amicus Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags(Simply Wall St.)
2024-11-07 10:39
Amicus' Q3 Earnings & Revenues Beat Estimates, '24 View Updated(Zacks)
2024-11-07 09:50
Here's Why Amicus Therapeutics (FOLD) is a Strong Momentum Stock(Zacks)
2024-11-07 02:09
Amicus Therapeutics Inc (FOLD) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...(GuruFocus.com)
2024-11-07 00:26
Q3 2024 Amicus Therapeutics Inc Earnings Call(Thomson Reuters StreetEvents)
2024-11-06 20:30
Here's What Key Metrics Tell Us About Amicus Therapeutics (FOLD) Q3 Earnings(Zacks)
2024-11-06 08:25
Amicus Therapeutics (FOLD) Q3 Earnings and Revenues Beat Estimates(Zacks)
2024-11-06 08:13
Amicus Therapeutics Swings to Q3 Non-GAAP Net Income, Sales Gain; Raises 2024 Revenue Growth Guidance; Shares Rise Pre-Bell(MT Newswires)
2024-11-06 07:22
Amicus Therapeutics: Q3 Earnings Snapshot(Associated Press Finance)
2024-11-06 07:00
Amicus Therapeutics Announces Third Quarter 2024 Financial Results and Corporate Updates(GlobeNewswire)
2024-11-05 18:00
Amicus Therapeutics Announces Third Quarter 2024 Financial Results and Corporate Updates(Globenewswire)
2024-11-04 09:55
Wall Street Analysts Predict a 51.09% Upside in Amicus Therapeutics (FOLD): Here's What You Should Know(Zacks)
2024-11-01 07:00
Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2024(GlobeNewswire)
2024-10-31 19:00
Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2024(Globenewswire)
2024-10-31 10:02
Will Mirum Pharmaceuticals, Inc. (MIRM) Report Negative Q3 Earnings? What You Should Know(Zacks)
2024-10-30 10:01
Amicus Therapeutics (FOLD) Reports Next Week: Wall Street Expects Earnings Growth(Zacks)
2024-10-28 07:00
Amicus Therapeutics to Announce Third Quarter 2024 Financial Results on November 6, 2024(GlobeNewswire)
2024-10-27 19:00
Amicus Therapeutics to Announce Third Quarter 2024 Financial Results on November 6, 2024(Globenewswire)
2024-10-25 08:46
GitLab and Baidu have been highlighted as Zacks Bull and Bear of the Day(Zacks)
2024-10-24 10:15
Best Momentum Stocks to Buy for October 24th(Zacks)
2024-10-21 09:50
Why Amicus Therapeutics (FOLD) is a Top Momentum Stock for the Long-Term(Zacks)
2024-10-18 12:20
Can Amicus Therapeutics (FOLD) Run Higher on Rising Earnings Estimates?(Zacks)
2024-10-18 10:33
FOLD Stock Rises on Settling Galafold Patent Dispute With Teva(Zacks)
2024-10-18 09:55
How Much Upside is Left in Amicus Therapeutics (FOLD)? Wall Street Analysts Think 43.44%(Zacks)
2024-10-18 09:55
Amicus Therapeutics (FOLD) Just Flashed Golden Cross Signal: Do You Buy?(Zacks)
2024-10-18 06:41
Amicus Therapeutics (FOLD) Stock Jumps 14.0%: Will It Continue to Soar?(Zacks)
2024-10-17 11:12
Update: Amicus Therapeutics Shares Surge After Settling Patent Suit Against Teva Pharmaceuticals With License Deal(MT Newswires)
2024-10-17 11:07
Amicus Therapeutics Settles Patent Lawsuit Teva Pharmaceuticals Over Generic Version Of Its Rare Genetic Disorder Drug(Benzinga)
2024-10-17 07:50
Amicus Therapeutics Settles Patent Suit Against Teva Pharmaceuticals with License Agreement(MT Newswires)

Page 1 of 8

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.